health
Sun Pharma bags rights to $3.7 billion cholesterol drug market globally
Sun Pharma will commercialise and manufacture LIB Therapeutics' once-monthly cholesterol drug outside the US and China after its EU approval
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Childhood Obesity: How Can It Be Avoided?
Newswise

WHO Reports Latest Global Trends in Cholera, Meningitis and Plague
The Indian Practitioner

Can Infections Cause Cancer? Lancet Study Links 1 In 8 Cancer Cases To Viruses
NDTV

India has PET-CT machines-So why are cancer patients still waiting for reports?
theweek.in

Decaf helps the memory, and caffeine eases anxiety: Coffee study
ThePrint